Does Weight Gain Associated with Thiazolidinedione Use Negatively Affect Cardiometabolic Health?
Author:
Affiliation:
1. Department of Family Medicine, Gachon University Gil Medical Center, Incheon, Korea
2. Department of Family Medicine, Gachon University Dong-Incheon Gil Hospital, Incheon, Korea
Publisher
Korean Society for the Study of Obesity
Subject
Endocrinology, Diabetes and Metabolism
Link
http://pdf.medrang.co.kr/KSSO2/2017/026/KSSO2026-02-05.pdf
Reference38 articles.
1. Thiazolidinediones and the Promise of Insulin Sensitization in Type 2 Diabetes
2. Thiazolidinediones and PPARγ agonists: time for a reassessment
3. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group.
4. Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes
5. Rosiglitazone plus metformin is effective and well tolerated in clinical practice: results from large observational studies in people with type 2 diabetes
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecular and pathophysiological relationship between obesity and chronic inflammation in the manifestation of metabolic dysfunctions and their inflammation‑mediating treatment options (Review);Molecular Medicine Reports;2024-04-09
2. Effect of combination pioglitazone with sodium‐glucose cotransporter‐2 inhibitors or glucagon‐like peptide‐1 receptor agonists on outcomes in type 2 diabetes: A systematic review, meta‐analysis, and real‐world study from an international federated database;Diabetes, Obesity and Metabolism;2024-04
3. Comparative Effectiveness of Antidiabetic Drugs as an Additional Therapy to Metformin in Women with Polycystic Ovary Syndrome: A Systematic Review of Metabolic Approaches;International Journal of Endocrinology;2024-03-11
4. Post-Translational Modifications and Diabetes;Biomolecules;2024-03-06
5. Pharmacotherapy causing weight gain and metabolic alteration in those with obesity and obesity‐related conditions: A review;Annals of the New York Academy of Sciences;2024-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3